Navigation Links
Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Date:6/24/2011

PARIS, June  24, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today data from four studies  of its once-daily GLP-1 receptor agonist Lyxumia® (lixisenatide) that  is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with  basal insulin. These data are being presented or published at the American Diabetes Association's 71st Scientific Sessions in San Diego, California.

Logo: http://photos.prnewswire.com/prnh/20110624/NY25833LOGO )

"Efficacy and Safety of Lixisenatide Once-Daily Versus Exenatide Twice-Daily in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-X)" [ABSTRACT 0033-LB]"Lixisenatide once daily demonstrated efficacy in blood glucose control by meeting an endpoint of non-inferiority  at week 24 in a head-to-head study versus exenatide twice daily," said Julio Rosenstock, MD, director of the Dallas Diabetes and Endocrine Center at Medical City Dallas and lead investigator of the GetGoal-X trial.

In the GetGoal-X trial, a randomized, open-label, active-controlled, two-arm parallel-group, multicenter study with a 24-week main treatment period, lixisenatide once daily achieved its primary endpoint of non-inferiority in A1C reduction from baseline with less symptomatic hypoglycemia (low blood sugar) and better gastrointestinal tolerability versus exenatide twice daily, as an add-on to metformin in patients with type 2 diabetes. A total of 634 people were randomized to receive either lixisenatide or exenatide. Both groups received a stepwise increase in dose, up to a maximum daily dose of 20 microgram.  At baseline, the mean age in the trial was 57.4 years, mean diabetes duration 6.8 years, mean body mass index (BMI) 33.
'/>"/>

SOURCE Euro RSCG Life
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  NxStage Medical, Inc. (Nasdaq: ... today announced that it has entered into new agreements ... products to DaVita, the kidney care division of DaVita Healthcare ... For the use of products for home ... NxStage has executed a second amended and restated National ...
(Date:5/21/2013)... N.Y., May 21, 2013  Lakeland Industries, Inc. ... manufacturer of industrial protective clothing for industry, municipalities, ... and local levels, today announced that the Company ... a Senior Credit Facility subject to certain terms ... this financing.  However, no assurances can be given ...
(Date:5/21/2013)... mayo de 2013 La junta directiva ... incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, SA, ... junta. Guy Mayer, un ejecutivo ortopédico experimentado, será vicepresidente ... Johnson , un experto refutado en dispositivos ... de unirse a OSI como presidente de la ...
Breaking Medicine Technology:NxStage Announces New Agreements with DaVita 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3
(Date:5/21/2013)... transformation on a large scale is the cornerstone ... achieving better outcomes, better value and better experience ... the patient-centered medical home model offers a viable ... Department of Health and Human Services, Agency for ... learn more about the processes and determinants of ...
(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and the YMCA ... Fair to educate the public on health initiatives and provide ... May 22, 2013 from 4:00 pm until 7:00 pm at ... Road, Charlotte, NC 29262). , Medic, the Y, ... County Department of Social Services are working toward a ...
(Date:5/21/2013)... Paris, France: The Orsiro stent, which is a ... polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting ... late lumen loss at nine months in the ... 2013 today. , The BIOFLOW-II substudy used intravascular ... quantitatively assess neointimal hyperplasia and stent apposition at ...
(Date:5/21/2013)... The In View series , ... cable channels across the country, announces it has posted ... The producers of the series proudly bring audiences across ... the manufacturing industry, health-related companies, medical facilities and more. ... practitioners in all parts of the United States, Canada ...
(Date:5/21/2013)... MedMar Healing Center announces their participation ... Food Bank. Twenty-eight businesses, including MedMar Healing Center, doctors, and ... The goal is to raise food to help area kids ... families in recent years. , “We like being able ... need,” explains Douglas Chloupek of MedMar Healing Center. “Taking part ...
Breaking Medicine News(10 mins):Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2
... Epstein-Barr virus (EBV) infects nine out of ten people ... early childhood often cause no disease symptoms, but people ... mononucleosis, a disease characterized by swollen lymph nodes, fever ... kinds of cancer, including Hodgkin lymphoma and stomach and ...
... , WEDNESDAY, Nov. 2 (HealthDay News) -- Although ... 15," most only put on between 2.5 to 3.5 pounds ... And, the researchers noted, this weight gain is typical ... "The ,freshman 15, is a media myth," study co-author ...
... Pittsburgh innovations that has moved from the lab to ... resulting in 105 licenses or options to industry and ... commercialization activity also included 37 U.S. patents that were ... of 257 new invention disclosures by Pitt faculty, according ...
... TUESDAY, Nov. 1 (HealthDay News) -- Folks genetically predisposed to ... by staying physically active, a new study suggests. A ... mass and obesity associated" (FTO) gene, which is known to ... effect on physically active adults compared to inactive ones. Their ...
... 2 (HealthDay News) -- Nearly half of 50 hospital ... a multidrug-resistant bacteria, a new study says. University ... baumannii (MDR-AB) bacteria on multiple surfaces, including bedrails, ... which has caused infection outbreaks in health care facilities ...
... in common? Perhaps more than meets the eye, according to ... A diverse group of scientists experts in cardiology, neurology, ... drugs that show promise in the treatment of dementia for ... In this case, the connection between the head and the ...
Cached Medicine News:Health News:NIH scientists outline steps toward Epstein-Barr virus vaccine 2Health News:No Such Thing as the 'Freshman 15,' Study Finds 2Health News:Two tech companies launched through Pitt research in 2011 2Health News:Exercise Might Help Thwart 'Obesity Gene' 2Health News:Hospital Rooms Crawling With Drug-Resistant Germs: Study 2Health News:Scientists explore whether what heals the head can also heal the heart 2Health News:Scientists explore whether what heals the head can also heal the heart 3
... xenon illumination for High ... instruments. Port allows use ... cables. Worldwide voltage and ... change drawer Infinite ...
... is so bright many surgeons turn it down ... shift into when the going gets tough. More ... true Hot Start and the technologically advanced fan ... prevent failed start ups and overheating. The result ...
... start circuit extends life of lamp Reserve lamp ... model allows simultaneous use with a reserve lamp ... unit cool.Worldwide voltage and electrical certification Lamp ... lamp Easy access to lamp for quick ...
... Lawson Lite positions directly over one,eye ... the lens an exclusive feature ... fiber optic light that penetrates,deep into ... universal swivel mount enables the,surgeon to ...
Medicine Products: